Lung Cancer Clinical Trials

Showing 4161-4180 of 4,288 trials

COMPLETED

Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy

NCT01213654

A pilot study to observe satisfaction of analgesia with intercostal catheters after VATS lobectomy.

Lung Cancer Patients

Rigshospitalet, Denmark50 participantsStarted Apr 2010

Copenhagen, Denmark

COMPLETEDPhase 2

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

NCT00085813

This study was designed to determine how effective and safe Ispinesib is in treating locally advanced or metastatic Non-small Cell Lung cancer in patients who have received a platinum-based chemotherapy and whose disease continues to progress. Treatment involves a 1-hr treatment given intravenously (IV), repeated once every 21 days. A patient may continue treatment as long as they are benefiting from the treatment. Blood samples will be taken at specific times over 24 hr period to measure the amount of drug in your body at specific times after the drug is given. Blood samples will also be taken for routine lab tests such as complete blood counts and clinical chemistries. Physical exams will be performed before each treatment.

Non-Small-Cell Lung Cancer

GlaxoSmithKline70 participantsStarted Dec 2003

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +8 more locations

UNKNOWN

Endoplasmic Reticulum Stress in Chronic Respiratory Diseases

NCT01211015

Aim: To investigate whether ER stress is implicated in the pathogenesis of various pulmonary disorders Measurement: 1. Unfolded protein responses (UPRs) in blood (PBMCs)of patients 1. CHOP 2. GRP 78 and so on 2. Unfolded protein responses (UPRs) in blood (PBMCs)of healthy controls 1. CHOP 2. GRP 78 and so on

ER Stress,Chronic Airway Disorders,Lung Cancer,+1 more

Chonbuk National University50 participantsStarted Jul 2010

Jeonju, Jeollabuk-do, South Korea

Inter Costal Catheters for Video-Assisted Thoroscopic (VATS) Lobectomy

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Endoplasmic Reticulum Stress in Chronic Respiratory Diseases

Related Searches

Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer

Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer

Concurrent Chemo-radiation Form NSCLC to a Individualized MLD

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)

A Retrospective Pharmacoeconomic Study of Lung Cancer

Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers